Preliminary results from PiSARRO, a phase Ib/II study of APR-246, a mutant p53 reactivating small molecule, in combination with standard chemotherapy in platinum-sensitive ovarian cancer
File(s)
aacr poster JAG.docx (369.59 KB)
Accepted version
Author(s)
von Euler, M
Wiman, KG
Gabra, H
Brenton, JD
Basu, B
Type
Conference Paper
Date Issued
2015-08-01
Date Acceptance
2015-04-18
Citation
Cancer Research, 2015, 75
URI
DOI
ISSN
1538-7445
Publisher
American Association for Cancer Research
Journal / Book Title
Cancer Research
Volume
75
Copyright Statement
© 2015 American Association for Cancer Research.
Sponsor
Ovarian Cancer Action
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000371597100039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
N/A
Source
106th Annual Meeting of the American-Association-for-Cancer-Research (AACR)
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
Publication Status
Published
Start Date
2015-04-18
Finish Date
2015-04-22
Coverage Spatial
Philadelphia, PA